Showing results (461-470 of 687) with videos related to

Sort By:
Pageof 69
Radiology|February 1, 1988
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanningJ A Parker, J E Markis, A Palla, et al.
Cancer Discovery|January 14, 2015
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic driversYan Li, Nilesh Chitnis, Hiroshi Nakagawa, et al.
JCI Insight|March 23, 2018
CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patientsTatiana A Karakasheva, George A Dominguez, Ayumi Hashimoto, et al.
The Journal of Clinical Investigation|November 27, 2008
A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specificationJiri Kalabis, Kenji Oyama, Takaomi Okawa, et al.
Hepatology (Baltimore, Md.)|June 10, 2008
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeksMorris Sherman, Cihan Yurdaydin, Halis Simsek, et al.
Cancer Cell|October 19, 2010
Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferasePriya Aggarwal, Laura Pontano Vaites, Jong Kyong Kim, et al.
Lancet (London, England)|March 20, 2004
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)Carol J Gallione, Gabriela M Repetto, Eric Legius, et al.
Oncogene|November 24, 2015
Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cellsS Diersch, M Wirth, C Schneeweis, et al.
The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.
Oncogenesis|August 7, 2013
Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironmentG S Wong, J-S Lee, Y-Y Park, et al.
Pageof 69